UTHR reports Wednesday, Feb 24, 2027, before the open. After the last 4 reports the stock moved +1.2%, +0.1%, +4.3%, +13.0% the next day.
UTHR is expected to report on Wednesday, Feb 24, 2027, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 4, 2026 | 6.04 | 5.71 | +1.2% | −2.1% |
| Aug 5, 2026 | 6.86 | 7.27 | +0.1% | −0.6% |
| May 6, 2026 | 6.86 | 5.82 | +4.3% | +1.7% |
| Feb 25, 2026 | 6.76 | 7.70 | +13.0% | +5.3% |
| Oct 29, 2025 | 6.96 | 7.16 | +9.6% | +5.3% |
| Jul 30, 2025 | 7.30 | 6.41 | −5.2% | +2.4% |
| Apr 30, 2025 | 6.54 | 6.63 | +0.8% | −1.9% |
| Feb 26, 2025 | 6.84 | 6.19 | −10.8% | −13.7% |
Average move the next trading day over the last 8 reports: ±5.6% (6 of 8 up).
UTHR is in an uptrend, momentum soft. $559.93 is the level overhead; $550 the first support below.
UTHR at $554.73. Nearest resistance $559.93 (+0.9%). Nearest support $550.00 (−0.9%).
UTHR chart, levels and analysis · Latest analysis: United Therapeutics (UTHR) stock analysis, November 16, 2026: bullish outlook on short‑term upside · Earnings this week
UTHR is expected to report on Wednesday, Feb 24, 2027, before the open.
UTHR reports before the open, US Eastern time.
After its report on Nov 4, 2026, UTHR moved +1.2% the next trading day.
Over the last 8 reports, UTHR moved 5.6% on average the next trading day, up 6 times out of 8.
Updated Nov 5, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.